CareersQuick FactsGlossarySite MapContact
Home Page
About Sepracor Products and Pipeline News and Media Therapeutic Areas
Scientific Abstracts : OMNARIS® brand ciclesonide Nasal Spray

2009 OMNARIS (ciclesonide) Abstracts

1. Prenner BM, Chervinsky P, Miller DL, Raphael G, Wingertzahn MA, Karafilidis J, Huang H. Long-term safety and efficacy of ciclesonide nasal spray in adolescents with perennial allergic rhinitis. Journal of Allergy & Clinical Immunology 2009;123(2):S132 (Abstract)

2. Karafilidis JG, Chervinsky P, Huang H. An evaluation of ciclesonide treatment in patients with PAR and co-morbid asthma. Am J Respir Crit Care Med 2009;179:A5706 (Abstract)

3. Karafilidis J, Chervinsky P, Wingertzahn M, Huang H. Efficacy of ciclesonide aqueous nasal spray for treatment of perennial allergic rhinitis by baseline severity. Rhinology World 2009 Program:111 (Abstract)

4. Nave R, Herzog R, Varga JM, Wingertzahn MA. Pharmacokinetics of ciclesonide and its active metabolite after administration via aqeous nasal spray or hydrofluoralkane nasal aerosol or orally inhaled ciclesonide. Presented as a poster presentation at Western Society of Allergy, Asthma & Immunology, January 25 - 29, 2009 in Wailea, Hawaii. (Abstract)

5. Nave R, Herzog R, Varga JM, Wingertzahn MA. Pharmacokinetics of ciclesonide and its active metabolite after administration via aqueous nasal spray or hydrofluoralkane nasal aerosol or orally inhaled ciclesonide. Presented as poster presentation # 18 at Western Society of Allergy, Asthma & Immunology, January 25 - 29, 2009 in Wailea, Hawaii. (Abstract)

2008 OMNARIS (ciclesonide) Abstracts

1. Blaiss M, Simmons L, Meltzer E, Sheth K, Boyle J. Sleep impairment in adults and children with allergic rhinitis. JACI 2008;121(2):S108 (Abstract)

2. Gordon B, Blaiss M, Meltzer E, Mahr T, Boyle J. Prevalence of seasonal and perennial allergic rhinitis in children and adults. JACI 2008;121(2):S209 (Abstract)

3. Mahr T, Derebery J, Simmons L, Sheth K, Boyle J. Allergies in America: A comparison of symptoms reported by adults and children. JACI 2008;121(2):S61 (Abstract)

4. Meltzer E, Gordon B, Derebery J, Blaiss M, Boyle J. Decreased quality of life and performance in children and adults with nasal allergy symptoms. JACI 2008;121(2):S107 (Abstract)

5. Sheth K, Derebery J, Mahr T, Simmons L, Boyle J. Ineffective control of allergic rhinitis symptoms reduces patient satisfaction and adherence with treatment. JACI 2008;121(2):S106 (Abstract)

6. van Bavel J, LaForce C, Meltzer E, Chia V, Darken P, Wingertzahn M. Effectiveness of ciclesonide nasal aerosol in adult and adolescent patients with seasonal allergic rhinitis (SAR). JACI 2008;121(2):S53 (Abstract)

7. Weiswasser M, Zhu J, Chia V, Nave R, Wingertzahn M. Low systemic bioavailability of ciclesonide aqueous nasal spray and ciclesonide HFA nasal aerosol compared with orally inhaled ciclesonide. JACI 2008;121(2):S53 (Abstract)

8. Derebery J, Meltzer EO, Boyle J. Facial symptoms related to allergic rhinitis in US children. Otolaryngology - Head and Neck Surgery 2008; 139(2S1):159 [Abstract]

9. Blaiss MS, Derebery MJ, Meltzer EO, Naclerio RM, Wingertzahn M, Regional prevalence of allergic rhinitis symptoms: findings from the Pediatric Allergies in America Survey. Annals of Allergy, Asthma & Immunology 2009;102(1 Suppl):A9 (Abstract)

10. Meltzer EO, Blaiss MS, Derebery MJ, Naclerio RM, Wingertzahn M. Prevalence of conditions associated with allergic rhinitis in children and adults. Annals of Allergy, Asthma & Immunology 2009;102(1 Suppl):A10 (Abstract)

11. Naclerio RM, Derebery MJ, Meltzer EO, Blaiss MS, Wingertzahn M. Allergic rhinitis and common secondary symptoms: findings from the Pediatric Allergies in America Survey. Annals of Allergy, Asthma & Immunology 2009;102(1 Suppl):A10 (Abstract)

12. Ratner PH, Nave R, Wingertzahn M. Pharmacokinetics, pharmacodynamics, safety, and tolerability of ciclesonide hydrofluoroalkane nasal aerosol. Annals of Allergy, Asthma & Immunology 2009;102(1 Suppl):A11 (Abstract)

13. Nave R, Weiswasser M, Zhu J, Herzog R, Chia V, Wingertzahn M. Low systemic exposure of desisobutyrylciclesonide after treatment with ciclesonide nasal sprays (aqueous and hyudrofluoralkane nasal aerosol) compared to orally inhaled ciclesonide. AJRCCM 2008;177(Supplement):A618 (Abstract)

14. Sheth KK, Meltzer EO, Boyle JM. Prevalence of concomitant asthma in adults and children with allergic rhinitis. AJRCCM 2008;177(Supplement):A624 (Abstract)

15. Berger WE, Nayak A, Lanier BQ, Kaiser HB, LaForce C, Darken P, Hall N, Wingertzahn M. Efficacy and safety of once-daily ciclesonide nasal spray in children with allergic rhinitis. Pediatric Asthma, Allergy & Immunology 2008;21:73-82.

16. Dhillon S, Wagstaff AJ. Ciclesonide nasal spray in allergic rhinitis. Drugs 2008;68(6):875-883.

17. Patel P, Patel D, Kunjibettu S, Hall N, Wingertzahn MA. Onset of action of ciclesonide once daily in the treatment of seasonal allergic rhinitis. Ear Nose Throat J 2008;87(6):340-353.